Optimizing the Value Proposition in Small Companies with Limited Budgets

From the DPHARM 2024 Archives: Biogen Pilot on Using Vocal Biomarkers to Identify Potential Participants for Clinical Trials

Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement

Ensuring Continuity in Patient Insights to Strengthen Medicine Development

Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Directors' Talk DPHARM 2025 - AI Sessions; Part III

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

Catalyzing Change: The Business Imperative of Patient-Centric Drug Development

How Emerging Biopharma CMOs Can Better Partner with Patient Organizations

Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges

What to Expect at the CRAACO: Clinical Research as a Care Option 2025 Event

Directors' Talk PODD 2025 - Keynotes & Key Themes

Enhanced Strategic FDA Collaboration: Working with CDER and CBER

Biomaterial Implants to Reduce Patient Burden and Improve Adherence

Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?

2025 Biotech Markets & Immuno-Oncology Outlook